cancerspЮжно-Российский онкологический журнал/ South Russian Journal of CancerSouth Russian Journal of Cancer2686-9039АНО "Перспективы онкологии"10.37748/2687-0533-2020-1-2-5cancersp-58Research ArticleОБЗОРЫREVIEWSОБЪЕДИНЕННЫЙ ИММУНОЛОГИЧЕСКИЙ ФОРУМ: СОВРЕМЕННЫЕ НАПРАВЛЕНИЯ РАЗВИТИЯ ФУНДАМЕНТАЛЬНОЙ И ПРИКЛАДНОЙ ОНКОИММУНОЛОГИИ (НОВОСИБИРСК, 2019)UNITED IMMUNOLOGICAL FORUM: CURRENT TRENDS IN THE DEVELOPMENT OF FUNDAMENTAL AND APPLIED ONCOIMMUNOLOGY (NOVOSIBIRSK, 2019)https://orcid.org/0000-0003-0874-5261СагакянцА. Б.SagakyantsA. B.

к.б.н., доцент, руководитель лаборатории иммунофенотипирования опухолейSPIN: 7272-1408, AuthorID: 426904 Scopus Author ID: 24329773900 Researcher ID: M-8378-2019

344037, Российская Федерация, г. Ростов-на-Дону, ул. 14-я линия, д. 63 

Cand. Sci. (Biol.), associate professor, head of the laboratory of tumor immunophenotyping

SPIN: 7272-1408, AuthorID: 426904, Scopus Author ID: 24329773900,

Researcher ID: M-8378-2019

63 14 line str., Rostov-on-Don 344037, Russian Federation

asagak@rambler.ruФГБУ «НМИЦ онкологии» Минздрава РоссииРоссияNational Medical Research Centre for Oncology of the Ministry of Health of RussiaRussian Federation202002062020123645Copyright © Сагакянц А.Б., 20202020Сагакянц А.Б.Sagakyants A.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.cancersp.com/jour/article/view/58фундаментальная и прикладная иммунологияонкоиммунологиясостояние и перспективы развития наукиврожденный и адаптивный иммунитетпротивоопухолевый иммунитетлимфоцитыцитокиныfundamental and applied immunologyoncoimmunologystate and prospects of development of scienceinnate and adaptive immunityantitumor immunitylymphocytescytokinesReferencesПроценко С. А., Антимоник Н. Ю., Берштейн Л. М., Новик А. В., Носов Д. А., Петенко Н. Н. и др. Практические рекомендации по управлению иммуноопосредованными нежелательными явлениями. Злокачественные опухоли: Практические рекомендации RUSSCO #3s2. 2018; 8(3s2): 636–665. https://doi.org/10.18027/2224–5057–2018–8-3s2–636–665Protsenko SA, Antimonik NYu, Bershtein LM, Novik AV, Nosov DA, Petenko NN, et al. Practical guidelines for managing immune‑mediated adverse events. Malignant tumors: Practical guidelines for RUSSCO #3s2. 2018; 8 (3s2): 636–665. https://doi.org/10.18027/2224–5057–2018–8‑3s2–636–665Савченко А. А., Борисов А. Г., Кудрявцев И. В., Гвоздев И. И., Мошев А. В. Особенности фенотипа дендритных клеток, дифференцированных из моноцитов крови, у больных раком почки. Медицинская иммунология. 2018; 20(2): 215–226. https://doi.org/10.15789/1563–0625–2018–2-215–226Savchenko AA, Borisov AG, Kudryavtsev IV, Gvozdev II, Moshev AV. Phenotypic peculiarities of dendritiс cells differentiated from blood monocytes in patients with kidney cancer. Medical Immunology. 2018; 20(2): 215–226. (In Russian). https://doi.org/10.15789/1563–0625–2018–2‑215–226Vlahakis A, Debnath J. The Interconnections between Autophagy and Integrin-Mediated Cell Adhesion. J Mol Biol. 2017 Feb 17; 429(4): 515–530. https://doi.org/10.1016/j.jmb.2016.11.027Vlahakis A, Debnath J. The Interconnections between Autophagy and Integrin‑Mediated Cell Adhesion. J Mol Biol. 2017 Feb 17; 429 (4): 515–530. https://doi.org/10.1016/j.jmb.2016.11.027Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C,, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007 Jan 4; 445(7123): 111–115. https://doi.org/10.1038/nature05384Ricci‑Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon‑cancer‑initiating cells. Nature. 2007 Jan 4; 445 (7123): 111–115. https://doi.org/10.1038/nature05384Qureshi-Baig K, Ullmann P, Rodriguez F, Frasquilho S, Nazarov PV, Haan S, et al. What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue. PLoS ONE. 2016 Jan 8; 11(1): e0146052. https://doi.org/10.1371/journal.pone.0146052Qureshi‑Baig K, Ullmann P, Rodriguez F, Frasquilho S, Nazarov PV, Haan S, et al. What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue. PLoS ONE. 2016 Jan 8; 11 (1): e0146052. https://doi.org/10.1371/journal.pone.0146052Сагакянц А. Б., Новикова И. А., Ульянова Е. П., Золотарева Е. И., Шапошников А. В., Дженкова Е. А. Опухолевые стволовые клетки и их микроокружение: роль в развитии опухоли. Российский иммунологический журнал. 2019; 13(22) (2): 512–514.Sagakyants AB, Novikova IA, Ulyanova EP, Zolotareva EI, Shaposhnikov AV, Dzhenkova EA. Tumor stem cells and their micro‑environment: the role in the development of the tumor. Russian journal of immunology. 2019; 13 (22) (2): 512–514. (In Russian).Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000 Jan 7; 100(1): 57–70. https://doi.org/10.1016/s0092–8674(00)81683–9Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000 Jan 7;100 (1): 57–70. https://doi.org/10.1016/s0092–8674 (00)81683–9Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011 Mar 25; 331(6024): 1565–1570. https://doi.org/10.1126/science.1203486Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011 Mar25; 331 (6024): 1565–1570. https://doi.org/10.1126/science.1203486Mantovanni A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature.2008 Jul 24; 454(7203): 436–444. https://doi.org/10.1038/nature07205Mantovanni A, Allavena P, Sica A, Balkwill F. Cancer‑related inflammation. Nature. 2008 Jul 24; 454 (7203): 436–444. https://doi.org/10.1038/nature07205Fang D, Zhu J. Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets. J. Exp. Med. 2017 Jul 3; 214(7): 1861–1876. https://doi.org/10.1084/jem.20170494Fang D, Zhu J. Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets. J. Exp. Med. 2017 Jul 3; 214 (7): 1861–1876. https://doi.org/10.1084/jem.20170494Rupaimoole R, Calin GA, Lopez-Berestein G, Sood AK. MicroRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 2016 Mar; 6(3): 235–246. https://doi.org/10.1158/2159–8290.CD-15–0893Rupaimoole R, Calin GA, Lopez‑Berestein G, Sood AK. MicroRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 2016 Mar; 6(3): 235–246. https://doi.org/10.1158/2159–8290.CD‑15–0893Teng MWL, Ngiow SF, Ribas A, Smyth MJ. Classifying Cancers Based on T-cell Infiltration and PD-L1. Cancer Res. 2015 Jun; 75(11): 2139–2145.https://doi.org/10.1158/0008–5472.CAN-15–0255Teng MWL, Ngiow SF, Ribas A, Smyth MJ. Classifying Cancers Based on T‑cell Infiltration and PD‑L1. Cancer Res. 2015 Jun; 75 (11): 2139–2145. https://doi.org/10.1158/0008–5472.CAN‑15–0255Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014 Mar 27; 157(1): 121–141. https://doi.org/10.1016/j.cell.2014.03.011Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014 Mar 27; 157 (1): 121–141. https://doi.org/10.1016/j.cell.2014.03.011Villéger R, Lopès A, Veziant J, Gagnière J, Barnich N, Billard E, et al. Microbial markers in colorectal cancer detection andor prognosisWorld J. Gastroenterol. 2018 Jun 14; 24(22): 2327–2347. https://doi.org/10.3748/wjg.v24.i22.2327Villéger R, Lopès A, Veziant J, Gagnière J, Barnich N, Billard E, et al. Microbial markers in colorectal cancer detection and or prognosis World J. Gastroenterol. 2018 Jun 14; 24 (22): 2327–2347. https://doi.org/10.3748/wjg.v24.i22.2327Greenplate AR, Johnson DB, Ferrell JrPB, Irish JM. Systems immune monitoring in cancer therapy. Eur J Cancer. 2016 Jul 1; 61: 77–84. https://doi.org/10.1016/j.ejca.2016.03.085Greenplate AR, Johnson DB, Ferrell JrPB, Irish JM. Systems immune monitoring in cancer therapy. Eur J Cancer. 2016 Jul 1; 61: 77–84. https://doi.org/10.1016/j.ejca.2016.03.085Spitzer MH, Nolan GP. Mass Cytometry: Single Cells, Many Features. Cell. 2016 May 5; 165(4): 780–791. http://dx.doi.org/10.1016/j.cell.2016.04.019Spitzer MH, Nolan GP. Mass Cytometry: Single Cells, Many Features. Cell. 2016 May 5; 165 (4): 780–791. https://doi.org/10.1016/j.cell.2016.04.019Chattopadhyay PK, Roederer M. A mine is a terrible thing to waste: high content, single cell technologies for comprehensive immune analysis. American Journal of Transplantation 2015; 15: 1155–1161. https://doi.org/10.1111/ajt.13193Chattopadhyay PK, Roederer M. A mine is a terrible thing to waste: high content, single cell technologies for comprehensive immune analysis. American Journal of Transplantation 2015; 15: 1155–1161. https://doi.org/10.1111/ajt.13193Li N, V van Unen, Abdelaa T, Guo N, Kasatskaya SA, Ladell K, et al. Memory CD4+ T cells are generated in the human fetal intestine. Nat Immunol. 2019; 20(3): 301–312. https://doi.org/10.1038/s41590–018–0294–9Li N, V van Unen, Abdelaa T, Guo N, Kasatskaya SA, Ladell K, et al. Memory CD4+ T cells are generated in the human fetal intestine. Nat Immunol. 2019; 20 (3): 301–312. https://doi.org/10.1038/s41590–018–0294–9Chen Z, Huang A, Sun J, Jiang T, Qin F, Wu A. Inference of immune cell composition on the expression profiles of mouse tissue. Sci Rep. 2017 Jan 13; 7: 40508. https://doi.org/10.1038/srep40508Chen Z, Huang A, Sun J, Jiang T, Qin F, Wu A. Inference of immune cell composition on the expression profiles of mouse tissue. Sci Rep. 2017 Jan 13; 7: 40508. https://doi.org/10.1038/srep40508

The authors declare that there are no conflicts of interest present.